Tim Luker, Ph.D.VP, Emerging Technology & Innovation at Eli Lilly & Company
Tim Luker is currently VP Emerging Technology and Innovation at Eli Lilly. He leads Lilly's external innovation process in Europe within Global Corporate Business Development, primarily targeting transformational early stage research across 5 therapy areas. This role also supports Lilly’s multiple external VC fund investments and runs due diligence and search and evaluation initiatives.
Tim is an experienced drug hunter with >20 years’ experience (>60 patents and publications). Prior to Lilly he worked at Shire, Polleo Pharma (founder, company acquired) and AstraZeneca.
Tim has a PhD in chemistry from the University of Southampton, carried out post-doctoral research at Universiteit Van Amsterdam and is a Prince2 qualified project manager.